Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Hold at BidaskClub

Phibro Animal Health (NASDAQ:PAHC) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports.

A number of other analysts have also issued reports on PAHC. Gabelli upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 target price on the stock in a research report on Wednesday, May 8th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Triple-S Management from a “hold” rating to a “buy” rating and set a $26.00 price target on the stock in a report on Monday, April 29th. ValuEngine lowered shares of Verso from a “hold” rating to a “sell” rating in a report on Thursday, May 23rd. Guggenheim reiterated a “buy” rating and issued a $95.00 price target (up previously from $90.00) on shares of VF in a report on Thursday, May 23rd. Finally, Barclays reiterated a “hold” rating on shares of Bank of Montreal in a report on Tuesday, June 11th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Phibro Animal Health has a consensus rating of “Hold” and an average price target of $41.50.

Shares of NASDAQ PAHC opened at $30.51 on Friday. Phibro Animal Health has a 1 year low of $27.32 and a 1 year high of $54.62. The stock’s 50 day moving average price is $30.35. The firm has a market capitalization of $1.23 billion, a price-to-earnings ratio of 18.49, a P/E/G ratio of 4.28 and a beta of 0.74. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, May 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The firm had revenue of $205.70 million for the quarter, compared to analyst estimates of $214.94 million. During the same quarter last year, the business posted $0.46 EPS. The firm’s revenue was down 1.5% compared to the same quarter last year. Analysts anticipate that Phibro Animal Health will post 1.52 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Northern Trust Corp boosted its holdings in shares of Phibro Animal Health by 8.0% in the 4th quarter. Northern Trust Corp now owns 452,913 shares of the company’s stock valued at $14,566,000 after purchasing an additional 33,656 shares during the last quarter. Laurion Capital Management LP boosted its holdings in shares of Phibro Animal Health by 23.3% in the 1st quarter. Laurion Capital Management LP now owns 10,317 shares of the company’s stock valued at $340,000 after purchasing an additional 1,949 shares during the last quarter. New York State Common Retirement Fund boosted its holdings in shares of Phibro Animal Health by 12.8% in the 4th quarter. New York State Common Retirement Fund now owns 52,379 shares of the company’s stock valued at $1,685,000 after purchasing an additional 5,947 shares during the last quarter. United Services Automobile Association boosted its holdings in shares of Phibro Animal Health by 11.2% in the 4th quarter. United Services Automobile Association now owns 17,188 shares of the company’s stock valued at $553,000 after purchasing an additional 1,734 shares during the last quarter. Finally, Martingale Asset Management L P boosted its holdings in shares of Phibro Animal Health by 15.7% in the 1st quarter. Martingale Asset Management L P now owns 153,745 shares of the company’s stock valued at $5,075,000 after purchasing an additional 20,898 shares during the last quarter. Institutional investors own 50.19% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: Market Capitalization – What it Means for Investors

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.